UNIVERSAL TECHNICAL INSTITUT (UTI) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:UTI - US9139151040 - Common Stock
24.84 USD
-0.15 (-0.6%)
24.3402 USD
-0.5 (-2.01%)
Taking everything into account, UTI scores 5 out of 10 in our fundamental rating. UTI was compared to 77 industry peers in the Diversified Consumer Services industry. UTI has an excellent profitability rating, but there are some minor concerns on its financial health. UTI is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
UTI had positive earnings in the past year.
In the past year UTI had a positive cash flow from operations.
Each year in the past 5 years UTI has been profitable.
UTI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 7.63%, UTI is in the better half of the industry, outperforming 73.68% of the companies in the same industry.
UTI's Return On Equity of 19.21% is amongst the best of the industry. UTI outperforms 84.21% of its industry peers.
The Return On Invested Capital of UTI (10.46%) is better than 84.21% of its industry peers.
The Average Return On Invested Capital over the past 3 years for UTI is in line with the industry average of 9.07%.
The 3 year average ROIC (7.27%) for UTI is below the current ROIC(10.46%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.63% | ||
| ROE | 19.21% | ||
| ROIC | 10.46% |
ROA(3y)4.45%
ROA(5y)3.5%
ROE(3y)11.95%
ROE(5y)9.34%
ROIC(3y)7.27%
ROIC(5y)5.89%
1.3 Margins
The Profit Margin of UTI (7.54%) is better than 67.11% of its industry peers.
UTI's Profit Margin has improved in the last couple of years.
UTI has a Operating Margin of 9.99%. This is in the better half of the industry: UTI outperforms 65.79% of its industry peers.
UTI's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 49.68%, UTI perfoms like the industry average, outperforming 52.63% of the companies in the same industry.
UTI's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.99% | ||
| PM (TTM) | 7.54% | ||
| GM | 49.68% |
OM growth 3Y17.03%
OM growth 5YN/A
PM growth 3Y35.13%
PM growth 5Y53.06%
GM growth 3Y-13.36%
GM growth 5Y-8.21%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UTI is creating some value.
UTI has more shares outstanding than it did 1 year ago.
UTI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for UTI has been reduced compared to a year ago.
2.2 Solvency
UTI has an Altman-Z score of 3.17. This indicates that UTI is financially healthy and has little risk of bankruptcy at the moment.
UTI's Altman-Z score of 3.17 is fine compared to the rest of the industry. UTI outperforms 77.63% of its industry peers.
UTI has a debt to FCF ratio of 1.57. This is a very positive value and a sign of high solvency as it would only need 1.57 years to pay back of all of its debts.
UTI's Debt to FCF ratio of 1.57 is amongst the best of the industry. UTI outperforms 84.21% of its industry peers.
UTI has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
UTI has a Debt to Equity ratio (0.26) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 1.57 | ||
| Altman-Z | 3.17 |
ROIC/WACC1.23
WACC8.48%
2.3 Liquidity
UTI has a Current Ratio of 1.07. This is a normal value and indicates that UTI is financially healthy and should not expect problems in meeting its short term obligations.
UTI has a Current ratio (1.07) which is comparable to the rest of the industry.
A Quick Ratio of 1.07 indicates that UTI should not have too much problems paying its short term obligations.
The Quick ratio of UTI (1.07) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.07 | ||
| Quick Ratio | 1.07 |
3. Growth
3.1 Past
UTI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.05%, which is quite impressive.
UTI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 65.96% yearly.
The Revenue has grown by 14.05% in the past year. This is quite good.
The Revenue has been growing by 22.67% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)54.05%
EPS 3Y3.11%
EPS 5Y65.96%
EPS Q2Q%0%
Revenue 1Y (TTM)14.05%
Revenue growth 3Y25.89%
Revenue growth 5Y22.67%
Sales Q2Q%13.28%
3.2 Future
The Earnings Per Share is expected to decrease by -11.46% on average over the next years. This is quite bad
The Revenue is expected to grow by 9.04% on average over the next years. This is quite good.
EPS Next Y-29.91%
EPS Next 2Y-11.46%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.06%
Revenue Next 2Y9.04%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 21.79, UTI is valued on the expensive side.
UTI's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of UTI to the average of the S&P500 Index (26.56), we can say UTI is valued inline with the index average.
A Price/Forward Earnings ratio of 31.09 indicates a quite expensive valuation of UTI.
UTI's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.79, UTI is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.79 | ||
| Fwd PE | 31.09 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, UTI is valued a bit cheaper than the industry average as 63.16% of the companies are valued more expensively.
UTI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. UTI is cheaper than 67.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.43 | ||
| EV/EBITDA | 10.55 |
4.3 Compensation for Growth
The decent profitability rating of UTI may justify a higher PE ratio.
UTI's earnings are expected to decrease with -11.46% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.33
EPS Next 2Y-11.46%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for UTI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
24.84
-0.15 (-0.6%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners94.95%
Inst Owner Change-1.21%
Ins Owners2.24%
Ins Owner Change5.47%
Market Cap1.35B
Revenue(TTM)835.62M
Net Income(TTM)63.02M
Analysts81.82
Price Target38.18 (53.7%)
Short Float %3.85%
Short Ratio2.77
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0.03
Dividend Growth(5Y)-34.43%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)49.09%
Min EPS beat(2)28.91%
Max EPS beat(2)69.26%
EPS beat(4)4
Avg EPS beat(4)73.64%
Min EPS beat(4)28.91%
Max EPS beat(4)123.12%
EPS beat(8)7
Avg EPS beat(8)75.72%
EPS beat(12)10
Avg EPS beat(12)77.26%
EPS beat(16)14
Avg EPS beat(16)214.91%
Revenue beat(2)2
Avg Revenue beat(2)0.81%
Min Revenue beat(2)0.47%
Max Revenue beat(2)1.15%
Revenue beat(4)4
Avg Revenue beat(4)2.24%
Min Revenue beat(4)0.47%
Max Revenue beat(4)4.51%
Revenue beat(8)8
Avg Revenue beat(8)2.25%
Revenue beat(12)12
Avg Revenue beat(12)3.17%
Revenue beat(16)15
Avg Revenue beat(16)3.41%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-43.74%
EPS NQ rev (3m)-44.7%
EPS NY rev (1m)-14.26%
EPS NY rev (3m)-20.2%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-0.73%
Revenue NY rev (1m)0.75%
Revenue NY rev (3m)0.71%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.79 | ||
| Fwd PE | 31.09 | ||
| P/S | 1.62 | ||
| P/FCF | 24.43 | ||
| P/OCF | 13.89 | ||
| P/B | 4.12 | ||
| P/tB | 4.79 | ||
| EV/EBITDA | 10.55 |
EPS(TTM)1.14
EY4.59%
EPS(NY)0.8
Fwd EY3.22%
FCF(TTM)1.02
FCFY4.09%
OCF(TTM)1.79
OCFY7.2%
SpS15.35
BVpS6.03
TBVpS5.19
PEG (NY)N/A
PEG (5Y)0.33
Graham Number12.43
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.63% | ||
| ROE | 19.21% | ||
| ROCE | 13.99% | ||
| ROIC | 10.46% | ||
| ROICexc | 14.6% | ||
| ROICexgc | 16.35% | ||
| OM | 9.99% | ||
| PM (TTM) | 7.54% | ||
| GM | 49.68% | ||
| FCFM | 6.62% |
ROA(3y)4.45%
ROA(5y)3.5%
ROE(3y)11.95%
ROE(5y)9.34%
ROIC(3y)7.27%
ROIC(5y)5.89%
ROICexc(3y)10.21%
ROICexc(5y)8.25%
ROICexgc(3y)11.54%
ROICexgc(5y)9.21%
ROCE(3y)9.72%
ROCE(5y)7.88%
ROICexgc growth 3Y34.26%
ROICexgc growth 5YN/A
ROICexc growth 3Y33.76%
ROICexc growth 5YN/A
OM growth 3Y17.03%
OM growth 5YN/A
PM growth 3Y35.13%
PM growth 5Y53.06%
GM growth 3Y-13.36%
GM growth 5Y-8.21%
F-Score6
Asset Turnover1.01
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 1.57 | ||
| Debt/EBITDA | 0.72 | ||
| Cap/Depr | 127.37% | ||
| Cap/Sales | 5.02% | ||
| Interest Coverage | 14.13 | ||
| Cash Conversion | 83.6% | ||
| Profit Quality | 87.84% | ||
| Current Ratio | 1.07 | ||
| Quick Ratio | 1.07 | ||
| Altman-Z | 3.17 |
F-Score6
WACC8.48%
ROIC/WACC1.23
Cap/Depr(3y)145.01%
Cap/Depr(5y)268.95%
Cap/Sales(3y)5.89%
Cap/Sales(5y)11.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.05%
EPS 3Y3.11%
EPS 5Y65.96%
EPS Q2Q%0%
EPS Next Y-29.91%
EPS Next 2Y-11.46%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.05%
Revenue growth 3Y25.89%
Revenue growth 5Y22.67%
Sales Q2Q%13.28%
Revenue Next Year9.06%
Revenue Next 2Y9.04%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y36.41%
EBIT growth 3Y47.33%
EBIT growth 5YN/A
EBIT Next Year47.87%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-10.14%
FCF growth 3YN/A
FCF growth 5Y99.08%
OCF growth 1Y13.31%
OCF growth 3Y28.35%
OCF growth 5Y54.57%
UNIVERSAL TECHNICAL INSTITUT / UTI FAQ
What is the fundamental rating for UTI stock?
ChartMill assigns a fundamental rating of 5 / 10 to UTI.
Can you provide the valuation status for UNIVERSAL TECHNICAL INSTITUT?
ChartMill assigns a valuation rating of 3 / 10 to UNIVERSAL TECHNICAL INSTITUT (UTI). This can be considered as Overvalued.
Can you provide the profitability details for UNIVERSAL TECHNICAL INSTITUT?
UNIVERSAL TECHNICAL INSTITUT (UTI) has a profitability rating of 7 / 10.
What are the PE and PB ratios of UNIVERSAL TECHNICAL INSTITUT (UTI) stock?
The Price/Earnings (PE) ratio for UNIVERSAL TECHNICAL INSTITUT (UTI) is 21.79 and the Price/Book (PB) ratio is 4.12.
Can you provide the expected EPS growth for UTI stock?
The Earnings per Share (EPS) of UNIVERSAL TECHNICAL INSTITUT (UTI) is expected to decline by -29.91% in the next year.